ID
15528
Descripción
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Please document clinically significant findings as Adverse Events. Clinical Significance is defined as any variation in physical findings that has medical relevance and may result in an alteration in medical care. Safety Blood and Urine Examinations: Please document the results for Serum Creatinine, Platelets and TSH on CRF-Pages "Safety Laboratory Assessments". Part: Month 3
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Palabras clave
Versiones (1)
- 2/6/16 2/6/16 -
Subido en
2 de junio de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Month 3: Vital Signs Multiple Sclerosis ALAIN01 NCT02419378
Month 3: Vital Signs Multiple Sclerosis ALAIN01 NCT02419378
- StudyEvent: SE
Similar models
Month 3: Vital Signs Multiple Sclerosis ALAIN01 NCT02419378
- StudyEvent: SE
C0449438 (UMLS CUI [1,2])
C0449438 (UMLS CUI [1,2])
C0018793 (UMLS CUI [1,2])
C0018793 (UMLS CUI [1,2])
C0024109 (UMLS CUI [1,2])
C0024109 (UMLS CUI [1,2])
C0000726 (UMLS CUI [1,2])
C0000726 (UMLS CUI [1,2])
C0278454 (UMLS CUI [1,2])
C0022417 (UMLS CUI [1,3])
C0022417 (UMLS CUI [1,2])
C0278060 (UMLS CUI [1,2])
C0278060 (UMLS CUI [1,2])
C0031809 (UMLS CUI [1,2])
C1705848 (UMLS CUI [1,3])
C0027365 (UMLS CUI [1,2])
C1519316 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])